US EditionPublished • loading... • Updated
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display
Summary by pirbright.ac.uk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display Having varied approaches to the design and manufacture of vaccines is critical in being able to respond to worldwide needs and newly emerging pathogens. Virus-like particles (VLPs) form the basis of two of the most successful licensed vaccines (against hepatitis B virus [HBV] and human papillomavirus). They are produced by recombinant expression of viral structural proteins, which …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
